Conversely, Nrf2 activation delayed DN progression by increasing the expression of the downstream antioxidant enzymes HO-1 and NADPH quinone oxidoreductase-1 (NQO-1) (100, 101). The gene discussed is NQO1; the disease is liver dysplastic nodule.